190 related articles for article (PubMed ID: 23842006)
1. C-erbB2/HER2 in human gliomas, medulloblastomas, and meningiomas: a minireview.
Waage IS; Vreim I; Torp SH
Int J Surg Pathol; 2013 Dec; 21(6):573-82. PubMed ID: 23842006
[TBL] [Abstract][Full Text] [Related]
2. ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas.
Tsai WC; Hueng DY; Nieh S; Gao HW
J Clin Pathol; 2017 Feb; 70(2):162-167. PubMed ID: 27451434
[TBL] [Abstract][Full Text] [Related]
3. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.
Loussouarn D; Brunon J; Avet-Loiseau H; Campone M; Mosnier JF
Hum Pathol; 2006 Apr; 37(4):415-21. PubMed ID: 16564915
[TBL] [Abstract][Full Text] [Related]
5. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas.
Tsai WC; Lee HS; Lin CK; Chen A; Nieh S; Ma HI
Histopathology; 2012 Nov; 61(5):844-56. PubMed ID: 22882568
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade.
Mahzouni P; Movahedipour M
Pathol Res Pract; 2012 Apr; 208(4):221-4. PubMed ID: 22420924
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin D and its prognostic value in neuroepithelial brain tumors.
Pigac B; Dmitrović B; Marić S; Masić S
Coll Antropol; 2012 Mar; 36(1):227-33. PubMed ID: 22816225
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
[TBL] [Abstract][Full Text] [Related]
9. The expression of hypoxia-inducible factor-1 in primary brain tumors.
Reszec J; Rutkowski R; Chyczewski L
Int J Neurosci; 2013 Sep; 123(9):657-62. PubMed ID: 23550771
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.
Andersson U; Guo D; Malmer B; Bergenheim AT; Brännström T; Hedman H; Henriksson R
Acta Neuropathol; 2004 Aug; 108(2):135-42. PubMed ID: 15148612
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin System Protein Expression Is Associated with Poor Clinical Outcome in Adult and Paediatric Gliomas and Medulloblastomas.
Yao A; Storr SJ; Al-Hadyan K; Rahman R; Smith S; Grundy R; Paine S; Martin SG
Mol Neurobiol; 2020 Jul; 57(7):2889-2901. PubMed ID: 32418115
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma.
Arrieta O; Garcia E; Guevara P; Garcia-Navarrete R; Ondarza R; Rembao D; Sotelo J
Cancer; 2002 Jun; 94(12):3210-8. PubMed ID: 12115353
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical study of extracellular matrices in human glioma and meningioma].
Wang L; Liang Y
Zhonghua Yi Xue Za Zhi; 1991 Feb; 71(2):81-3, 8. PubMed ID: 1647841
[TBL] [Abstract][Full Text] [Related]
14. Meningioma: Signaling pathways and tumor growth.
Burnett BA; Womeldorff MR; Jensen R
Handb Clin Neurol; 2020; 169():137-150. PubMed ID: 32553285
[TBL] [Abstract][Full Text] [Related]
15. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
[TBL] [Abstract][Full Text] [Related]
16. Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas.
Fung KM; Rorke LB; Giasson B; Lee VM; Trojanowski JQ
Acta Neuropathol; 2003 Aug; 106(2):167-75. PubMed ID: 12783249
[TBL] [Abstract][Full Text] [Related]
17. Recurrence in medulloblastoma - influence of clinical, histological and immunohistochemical factors.
Srikantha U; Balasubramaniam A; Santosh V; Somanna S; Bhagavatula ID; Ashwathnarayana CB
Br J Neurosurg; 2010 Jun; 24(3):280-8. PubMed ID: 20465457
[TBL] [Abstract][Full Text] [Related]
18. [Proliferative markers of meningiomas: immunohistochemical analysis and prognostic value].
Korshunov AG; Shishkina LV; Golanov AV
Arkh Patol; 2002; 64(1):29-33. PubMed ID: 11889696
[TBL] [Abstract][Full Text] [Related]
19. Expressions of Endocan in Patients with Meningiomas and Gliomas.
Atukeren P; Kunbaz A; Turk O; Kemerdere R; Ulu MO; Turkmen Inanir N; Tanriverdi T
Dis Markers; 2016; 2016():7157039. PubMed ID: 27528791
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG
Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
